85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

12 trials found

diseases per page:

Showing 1 to 10 of 12 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2051210169	16/01/2022	05/02/2022	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumabin S ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumabin S ...	Idiopathic Pulmonary Fibrosis	Pamrevlumabor placebo, 30 mg/kg, IV, Day 1 and every 3 weeks thereafter, up to Week 48, for a total ...	Tracy Ganske	NULL	Recruiting	>= 40age old	<= 85age old	Both	34	Phase 3	United States;Argentina;Chile;Russia;Australia;Taiwan;Hong Kong;South Korea;the People's Republic of ...
2	EUCTR2020-000697-22-IE (EUCTR)	04/05/2021	02/12/2020	A study to compare the use of Pamrevlumabwith Placebo in patients with Idiopathic Pulmonary Fibrosis ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Product Name: Pamrevlumab Product Code: FG-3019 INN or Proposed INN: PAMREVLUMAB	FibroGen, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 3	Serbia;Czechia;Spain;Ukraine;Ireland;Lebanon;Colombia;United Kingdom;Switzerland;Italy;France;Hungar ...
3	EUCTR2020-000697-22-PL (EUCTR)	13/04/2021	03/12/2020	A study to compare the use of Pamrevlumabwith Placebo in patients with Idiopathic Pulmonary Fibrosis ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Product Name: Pamrevlumab Product Code: FG-3019 INN or Proposed INN: PAMREVLUMAB	FibroGen, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 3	Serbia;Spain;Ukraine;Lebanon;Ireland;Colombia;Italy;India;France;Peru;Denmark;Netherlands;Czechia;Un ...
4	EUCTR2020-000697-22-NL (EUCTR)	24/12/2020	04/06/2020	A study to compare the use of Pamrevlumabwith Placebo in patients with Idiopathic Pulmonary Fibrosis ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Product Name: Pamrevlumab Product Code: FG-3019 INN or Proposed INN: PAMREVLUMAB	FibroGen, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 3	Serbia;Czechia;Spain;Ukraine;Ireland;Lebanon;Colombia;United Kingdom;Switzerland;Italy;France;Hungar ...
5	EUCTR2020-000697-22-DE (EUCTR)	13/10/2020	05/08/2020	A study to compare the use of Pamrevlumabwith Placebo in patients with Idiopathic Pulmonary Fibrosis ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Product Name: Pamrevlumab Product Code: FG-3019 INN or Proposed INN: PAMREVLUMAB	FibroGen, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 3	Serbia;Czechia;Spain;Ukraine;Ireland;Lebanon;Colombia;United Kingdom;Switzerland;Italy;France;Hungar ...
6	EUCTR2020-000697-22-DK (EUCTR)	13/10/2020	14/08/2020	A study to compare the use of Pamrevlumabwith Placebo in patients with Idiopathic Pulmonary Fibrosis ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Product Name: Pamrevlumab Product Code: FG-3019 INN or Proposed INN: PAMREVLUMAB	FibroGen, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 3	Serbia;Czechia;Spain;Ukraine;Ireland;Lebanon;Colombia;United Kingdom;Switzerland;Italy;France;Hungar ...
7	NCT04419558 (ClinicalTrials.gov)	September 30, 2020	3/6/2020	Zephyrus II: Efficacy and Safety Study of Pamrevlumabin Participants With Idiopathic Pulmonary Fibro ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis	Drug: Pamrevlumab;Drug: Placebo	FibroGen	NULL	Recruiting	40 Years	85 Years	All	340	Phase 3	United States;Argentina;Brazil;China;Colombia;Czechia;Denmark;Dominican Republic;France;Georgia;Germ ...
8	EUCTR2020-000697-22-IT (EUCTR)	29/07/2020	21/01/2021	A study to compare the use of Pamrevlumabwith Placebo in patients with Idiopathic Pulmonary Fibrosis ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Product Name: Pamrevlumab Product Code: [FG-3019] INN or Proposed INN: PAMREVLUMAB	FIBROGEN	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 3	Serbia;Czechia;Spain;Ukraine;Ireland;Lebanon;Colombia;United Kingdom;Italy;India;France;Hungary;Mexi ...
9	EUCTR2020-000697-22-HU (EUCTR)	08/07/2020	22/05/2020	A study to compare the use of Pamrevlumabwith Placebo in patients with Idiopathic Pulmonary Fibrosis ...	Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pa ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Product Name: Pamrevlumab Product Code: FG-3019 INN or Proposed INN: PAMREVLUMAB	FibroGen, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 3	Serbia;Spain;Ukraine;Lebanon;Ireland;Colombia;Italy;United Kingdom;India;France;Hungary;Czech Republ ...
10	NCT03955146 (ClinicalTrials.gov)	June 18, 2019	16/5/2019	Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumabin Participants With Idiopathic Pulmonar ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumabin S ...	Idiopathic Pulmonary Fibrosis	Drug: Pamrevlumab;Drug: Placebo	FibroGen	NULL	Active, not recruiting	40 Years	85 Years	All	356	Phase 3	United States;Argentina;Australia;Chile;China;Hong Kong;Korea, Republic of;Russian Federation;Taiwan ...

First Previous1 2Next Last